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LETTER T O THE EDITOR 
Exclusion of Interleukin-l Receptor Antagonist as a 
Primary Disease Determinant for Psoriasis 
To the Editor: 
Psoriasis is characterised by increased proliferation of epidermal 
cells and accumulation within lesional skin of inflammatory cells. 
Recently, it has been postulated that cytokines playa pivotal role in 
many of the pathways leading to the generation of a psoriatic plaque 
[1]. Furthermore, when the advancing edge of a psoriatic plaque is 
predicted by tracing, alterations in whole skin mRNA levels for 
certain cytokines can be detected in clinically normal-appearing 
perilesional skin [2]. Given that studies indicate an important 
genetic component to the development of the disease [3], these 
observations have led to the suggestion that cytokines may be major 
susceptibility genes for psoriasis. 
One such cytokine is interleukin-l receptor antagonist (IL-lra), 
a specific inhibitor of IL-l activity. Recently, polymorphisms in 
intron 2 of the IL- Ira gene have been described [4]. Disease 
association has recently been reported between an allele (A2) at the 
IL-lra locus and early onset psoriasis (35.5% compared to 22.9% for 
the control population) [5]. 
Disease allelic association is dependent upon careful population 
stratification, particularly for ethnic background. Furthermore, 
association may arise through linkage disequilibrium and does not 
indicate a causative role for the gene polymorphism under study. 
One alternative strategy is to identify genetic recombination be-
tween alleles at a given locus and the disease phenotype. This 
approach requires family linkage analysis. 
We have genotyped 30 multiplex psoriatic families using an 
intragenic tandem repeat sequence polymorphism within the IL-lra 
gene, located at chromosome 2q. As the mode of inheritance of 
psoriasis remains unclear, we performed two point linkage analysis 
under three different models of inheritance (see T able I). 
These data demonstrate exclusion of linkage to IL-lra extending 
over a minimum genetic distance of lcM. In conclusion, our data 
provides evidence that the IL-l ra gene is not a major primary 
genetic determinant for psoriasis disease susceptibility. The appli-
cation of dense micro satellite genetic mapping is proving successful 
in an increasing number of disorders whose pathogenesis has 
hitherto been unknown. A random genome search for linked loci is 
now underway using the families identified in this study . 
This work was supported by the Psoriasis A ssociation of G reat Brita in. 
Table I. Two-Point Linkage Analysis Between 
IL-1ra and Psoriasisa 
Recombination Fraction (e) 
Model 
(penetrance) 0.01 0.1 0.2 0.3 0.4 
AD (80%) -2.80 -1.50 -0.82 -0.42 -0.16 
AD (60%) -2.19 -1.16 -0.64 -0.33 -0.13 
AR (80%) - 2.50 - 1.22 -0.60 -0.26 -0.05 
a AD, autosomal dominant: gene frequen cy is 0.02, phenocopy rate is 3%. AR, 
autosomal recessive: gene frequency is 0.12, phenocopy rate is 3%. Two-point LOD 
score calculated using Linkage Version 5.2 program. 
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